Search Results - "Peerschke, Ellinor"
-
1
Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology
Published in The Journal of clinical investigation (01-11-2020)“…In a stunningly short period of time, the unexpected coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2…”
Get full text
Journal Article -
2
The complement and contact activation systems: partnership in pathogenesis beyond angioedema
Published in Immunological reviews (01-11-2016)“…Summary The blood plasma contains four biologically important proteolytic cascades, which probably evolved from the same ancestral gene. This in part may…”
Get full text
Journal Article -
3
Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor
Published in British journal of haematology (01-06-2016)Get full text
Journal Article -
4
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine
Published in Neurocritical care (01-02-2016)“…Background The use of antithrombotic agents, including anticoagulants, antiplatelet agents, and thrombolytics has increased over the last decade and is…”
Get full text
Journal Article -
5
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
Published in Neurocritical care (01-02-2016)“…BackgroundThe use of antithrombotic agents, including anticoagulants, antiplatelet agents, and thrombolytics has increased over the last decade and is expected…”
Get full text
Journal Article -
6
cC1qR/CR and gC1qR/p33: observations in cancer
Published in Molecular immunology (01-10-2014)“…The survival and growth of a primary tumor depends, by and large, on three major events: immune evasion, angiogenesis and metastasis. Tumor cells are "modified…”
Get full text
Journal Article -
7
Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura
Published in British journal of haematology (01-02-2010)“…Summary The role of the complement system in immune thrombocytopenic purpura (ITP) is not well defined. We examined plasma from 79 patients with ITP, 50…”
Get full text
Journal Article -
8
Complement activation on platelets: Implications for vascular inflammation and thrombosis
Published in Molecular immunology (01-08-2010)“…Platelets participate in a variety of responses of the blood to injury. An emerging body of evidence suggests that these cells express an intrinsic capacity to…”
Get full text
Journal Article -
9
C1q as an autocrine and paracrine regulator of cellular functions
Published in Molecular immunology (01-04-2017)“…•Monocyte/dendritic cell (DC) expressed C1q is a molecular sensor of danger.•Antigen-free C1q keeps DCs in a tolerogenic phenotype.•Danger-loaded C1q…”
Get full text
Journal Article -
10
SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems
Published in Frontiers in immunology (05-11-2021)“…Infection with SARS-CoV-2 triggers the simultaneous activation of innate inflammatory pathways including the complement system and the kallikrein-kinin system…”
Get full text
Journal Article -
11
Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage
Published in Journal of neuroinflammation (19-08-2011)“…Subarachnoid haemorrhage (SAH) elicits rapid pathological changes in the structure and function of parenchymal vessels (≤ 100 μm). The role of neutrophils in…”
Get full text
Journal Article -
12
Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19
Published in Frontiers in immunology (18-08-2021)“…COVID-19 pathology is associated with exuberant inflammation, vascular damage, and activation of coagulation. In addition, complement activation has been…”
Get full text
Journal Article -
13
SLE: Novel Postulates for Therapeutic Options
Published in Frontiers in immunology (07-10-2020)“…Genetic deficiency in C1q is a strong susceptibility factor for systemic lupus erythematosus (SLE). There are two major hypotheses that potentially explain the…”
Get full text
Journal Article -
14
-
15
Reference range determination for whole-blood platelet aggregation using the Multiplate analyzer
Published in American journal of clinical pathology (01-11-2014)“…To develop reference ranges for platelet aggregation using the Multiplate analyzer (Roche Diagnostics, Mannheim, Germany) in blood anticoagulated with sodium…”
Get full text
Journal Article -
16
DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells
Published in Blood (09-08-2012)“…C1q modulates the differentiation and function of cells committed to the monocyte-derived dendritic cell (DC) lineage. Because the 2 C1q receptors found on the…”
Get full text
Journal Article -
17
HITTING the Diagnosis: Testing for Heparin-Induced Thrombocytopenia in Cancer Patients
Published in American journal of clinical pathology (03-07-2018)“…To evaluate the use of a pretest probability score (4Ts score) in cancer patients to guide ordering of laboratory screening tests for heparin-induced…”
Get full text
Journal Article -
18
-
19
The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer
Published in Frontiers in immunology (22-04-2024)“…Understanding at the molecular level of the cell biology of tumors has led to significant treatment advances in the past. Despite such advances however,…”
Get full text
Journal Article -
20
von Willebrand Factor Assay Proficiency Testing: The North American Specialized Coagulation Laboratory Association Experience
Published in American journal of clinical pathology (01-06-2011)“…We evaluated the accuracy and precision of von Willebrand disease (vWD) testing performed by up to 50 North American Specialty Coagulation Laboratories from…”
Get full text
Journal Article